NPI: 1891731626 · TAMPA, FL 33617 · Clinical Medical Laboratory · NPI assigned 06/21/2006
Authorized official TIMMERMAN, LEAH controls 20+ related entities in our dataset. Read more
| Authorized Official | TIMMERMAN, LEAH (VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 06/21/2006 |
Other providers sharing the same authorized official: TIMMERMAN, LEAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 754,691 | $1.44M |
| 2019 | 2,130,778 | $6.98M |
| 2020 | 1,445,123 | $7.14M |
| 2021 | 1,630,838 | $8.74M |
| 2022 | 1,872,981 | $10.27M |
| 2023 | 1,942,655 | $9.41M |
| 2024 | 1,341,808 | $6.02M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 84,020 | 72,598 | $5.29M |
| 80061 | Lipid panel | 688,369 | 599,956 | $3.32M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 264,869 | 239,243 | $2.88M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 237,439 | 203,267 | $2.15M |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 8,984 | 8,318 | $1.89M |
| 83036 | Hemoglobin; glycosylated (A1C) | 449,228 | 388,064 | $1.58M |
| 86003 | 35,229 | 28,897 | $1.17M | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 263,593 | 238,035 | $1.14M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 71,881 | 65,713 | $1.08M |
| 87088 | 170,501 | 145,525 | $1.03M | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 69,686 | 63,572 | $927K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 9,222 | 8,435 | $924K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 79,444 | 73,545 | $917K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 63,982 | 56,805 | $897K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 256,414 | 220,453 | $872K |
| 80053 | Comprehensive metabolic panel | 874,646 | 739,385 | $819K |
| 80050 | General health panel | 59,900 | 58,458 | $799K |
| 84443 | Thyroid stimulating hormone (TSH) | 525,708 | 453,377 | $717K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 27,935 | 25,280 | $674K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 175,039 | 161,574 | $673K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 826,887 | 700,075 | $660K |
| 86480 | 33,674 | 30,411 | $640K | |
| 82728 | 100,236 | 87,604 | $587K | |
| 84439 | 210,440 | 184,469 | $586K | |
| 80074 | 32,824 | 29,049 | $574K | |
| 80055 | 23,442 | 22,089 | $502K | |
| 86803 | 103,300 | 94,731 | $500K | |
| 80081 | 22,128 | 21,092 | $468K | |
| 87340 | 78,149 | 71,869 | $440K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 19,889 | 13,460 | $436K |
| 82746 | 112,857 | 96,706 | $436K | |
| 81513 | 11,914 | 10,969 | $417K | |
| 36415 | Collection of venous blood by venipuncture | 387,918 | 323,482 | $412K |
| 87536 | 50,219 | 41,891 | $399K | |
| 81511 | 5,886 | 5,546 | $368K | |
| 82105 | 30,885 | 28,461 | $301K | |
| 84153 | 56,992 | 48,863 | $288K | |
| 86235 | 25,819 | 10,392 | $286K | |
| 83655 | 43,260 | 39,994 | $273K | |
| 81443 | 511 | 496 | $272K | |
| 88142 | 30,698 | 28,335 | $266K | |
| 82670 | 18,808 | 17,113 | $264K | |
| 83013 | 12,368 | 11,554 | $234K | |
| 87081 | 53,594 | 51,161 | $232K | |
| 82607 | 163,013 | 139,535 | $231K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,035 | 2,832 | $227K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1,801 | 1,667 | $204K |
| 82785 | 28,060 | 26,013 | $187K | |
| 87070 | 71,213 | 60,858 | $187K | |
| 84403 | 38,884 | 34,578 | $186K | |
| 86787 | 20,903 | 19,175 | $183K | |
| 84702 | 37,547 | 31,656 | $180K | |
| 84481 | 37,169 | 32,384 | $178K | |
| 81001 | 345,762 | 300,884 | $177K | |
| 87522 | Neg quan hep c or qual rna | 15,801 | 13,754 | $176K |
| 87209 | 19,804 | 16,293 | $173K | |
| 82627 | 10,392 | 9,647 | $167K | |
| 84146 | 23,524 | 21,409 | $162K | |
| 87186 | 82,986 | 68,474 | $160K | |
| 82652 | 19,847 | 16,715 | $156K | |
| 86038 | 40,873 | 35,980 | $148K | |
| 86592 | 143,121 | 130,249 | $141K | |
| 83970 | 34,126 | 27,935 | $138K | |
| 84402 | 17,444 | 15,747 | $138K | |
| 85660 | 20,319 | 18,963 | $130K | |
| 87902 | 2,599 | 2,321 | $125K | |
| 86800 | 17,781 | 16,063 | $122K | |
| 86696 | 20,667 | 18,521 | $117K | |
| 85652 | 74,876 | 63,286 | $111K | |
| 82784 | 24,198 | 21,263 | $111K | |
| 85027 | 126,448 | 112,044 | $110K | |
| 87799 | 36,852 | 14,498 | $104K | |
| 83001 | 27,844 | 25,492 | $101K | |
| 87449 | 10,080 | 8,351 | $82K | |
| 83020 | 16,083 | 15,448 | $82K | |
| 86160 | 17,296 | 10,313 | $81K | |
| 88141 | 13,340 | 12,185 | $81K | |
| 82570 | 166,516 | 139,503 | $78K | |
| 87901 | 2,955 | 2,527 | $76K | |
| 82150 | 12,455 | 10,827 | $76K | |
| 87338 | 12,462 | 11,618 | $74K | |
| 88342 | 3,881 | 2,200 | $71K | |
| 86360 | 38,402 | 31,340 | $70K | |
| 82550 | 22,096 | 18,116 | $70K | |
| 83735 | 49,635 | 37,261 | $66K | |
| 84480 | 30,047 | 26,109 | $64K | |
| 82951 | 11,286 | 10,674 | $63K | |
| 80349 | 4,260 | 3,971 | $61K | |
| 84479 | 38,279 | 33,921 | $60K | |
| 87481 | 5,191 | 2,986 | $59K | |
| 86665 | 5,309 | 3,829 | $59K | |
| 82950 | 47,983 | 45,419 | $58K | |
| 82465 | 10,671 | 9,849 | $58K | |
| 81243 | 4,599 | 4,233 | $58K | |
| 86695 | 20,669 | 18,687 | $57K | |
| 87480 | 6,879 | 6,326 | $56K | |
| 86762 | 15,126 | 13,996 | $53K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 65,232 | 52,736 | $53K |
| 86317 | 12,698 | 10,423 | $53K | |
| 81329 | 3,677 | 3,423 | $52K | |
| 86364 | 5,907 | 5,478 | $52K | |
| 85730 | 29,288 | 25,116 | $52K | |
| 82677 | 6,142 | 5,777 | $52K | |
| 83021 | 11,036 | 10,034 | $51K | |
| 84445 | 3,097 | 2,801 | $51K | |
| 84436 | 66,624 | 58,415 | $50K | |
| 83550 | 91,733 | 79,833 | $50K | |
| 86300 | 7,064 | 5,078 | $49K | |
| 83540 | 104,937 | 91,422 | $48K | |
| 82274 | 20,899 | 18,762 | $48K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,088 | 1,999 | $46K |
| 86706 | 26,121 | 23,495 | $45K | |
| 86769 | 9,143 | 7,759 | $44K | |
| 82378 | 10,532 | 8,751 | $44K | |
| 84144 | 11,226 | 10,039 | $44K | |
| 84681 | 8,421 | 7,523 | $43K | |
| 83525 | 24,393 | 22,202 | $43K | |
| 83615 | 14,610 | 12,250 | $43K | |
| 83002 | 24,618 | 22,519 | $43K | |
| 86021 | 3,859 | 3,336 | $43K | |
| 83993 | 5,866 | 5,386 | $42K | |
| 86850 | 14,400 | 13,451 | $42K | |
| 83880 | 9,486 | 7,373 | $41K | |
| 82977 | 11,378 | 9,758 | $40K | |
| 86704 | 27,175 | 24,355 | $39K | |
| 83921 | 3,916 | 3,242 | $39K | |
| 87077 | 76,780 | 64,486 | $39K | |
| 86140 | 67,853 | 56,520 | $38K | |
| 81229 | 926 | 835 | $38K | |
| 82043 | 135,463 | 114,365 | $38K | |
| 86304 | 4,613 | 3,977 | $37K | |
| 87660 | 6,832 | 6,270 | $36K | |
| 87631 | 1,821 | 1,609 | $36K | |
| 82947 | 13,907 | 12,669 | $35K | |
| 82533 | 8,051 | 6,940 | $34K | |
| 82672 | 4,480 | 4,153 | $34K | |
| 86780 | 12,305 | 10,845 | $34K | |
| 86146 | 4,990 | 2,775 | $34K | |
| 80348 | 1,584 | 1,439 | $33K | |
| 80164 | 13,783 | 11,564 | $33K | |
| 86336 | 6,151 | 5,782 | $32K | |
| 86708 | 23,181 | 20,665 | $32K | |
| 82103 | 2,084 | 1,872 | $32K | |
| 84305 | 5,695 | 5,232 | $32K | |
| 86008 | 5,601 | 5,121 | $31K | |
| 86481 | 692 | 682 | $31K | |
| 87512 | 14,872 | 13,342 | $31K | |
| 86376 | 26,880 | 24,211 | $31K | |
| 83520 | 17,732 | 9,785 | $31K | |
| 82085 | 2,346 | 2,054 | $30K | |
| 86334 | 8,232 | 6,755 | $30K | |
| 83521 | 3,469 | 1,579 | $29K | |
| 87900 | 2,954 | 2,526 | $29K | |
| 80197 | 18,709 | 12,030 | $29K | |
| 86225 | 10,824 | 9,583 | $28K | |
| 83090 | 8,076 | 6,432 | $28K | |
| 88112 | 5,500 | 3,346 | $28K | |
| 87205 | 15,465 | 12,306 | $27K | |
| 87497 | 4,206 | 2,675 | $27K | |
| 83516 | 15,487 | 9,388 | $27K | |
| 87075 | 11,901 | 9,448 | $26K | |
| 86147 | 7,761 | 3,204 | $26K | |
| 86644 | 1,764 | 1,573 | $25K | |
| 84154 | 8,718 | 7,355 | $25K | |
| 84550 | 55,130 | 46,572 | $25K | |
| 80323 | 1,457 | 1,358 | $25K | |
| 82024 | 2,993 | 2,608 | $24K | |
| 80361 | 3,837 | 3,596 | $24K | |
| 80076 | 21,068 | 18,816 | $23K | |
| 80373 | 1,930 | 1,809 | $23K | |
| 87625 | 2,078 | 1,898 | $22K | |
| 87150 | 3,026 | 2,940 | $21K | |
| 88230 | 392 | 359 | $21K | |
| 81512 | 850 | 805 | $21K | |
| 85247 | 389 | 372 | $20K | |
| 87517 | 2,842 | 2,403 | $20K | |
| 87563 | 3,400 | 3,115 | $20K | |
| 86765 | 6,250 | 5,787 | $20K | |
| 86200 | 12,575 | 10,954 | $20K | |
| 86361 | 13,273 | 10,961 | $19K | |
| 87506 | 299 | 284 | $19K | |
| 81025 | 1,899 | 1,761 | $19K | |
| 86341 | 1,590 | 876 | $19K | |
| 87046 | 6,374 | 5,356 | $19K | |
| 84207 | 2,495 | 2,156 | $18K | |
| 82157 | 750 | 720 | $18K | |
| 86777 | 2,607 | 2,310 | $18K | |
| 86255 | 8,257 | 5,614 | $17K | |
| 84466 | 4,286 | 3,682 | $17K | |
| 82626 | 506 | 463 | $17K | |
| 87510 | 6,834 | 6,280 | $16K | |
| 83690 | 15,779 | 13,761 | $16K | |
| 85610 | 53,920 | 43,568 | $16K | |
| 83498 | 3,259 | 3,097 | $16K | |
| 86735 | 5,821 | 5,418 | $16K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 655 | 635 | $15K |
| 87177 | 19,718 | 16,238 | $15K | |
| 86682 | 2,107 | 1,999 | $15K | |
| 88304 | 1,843 | 1,459 | $15K | |
| 85246 | 1,216 | 1,173 | $15K | |
| 86301 | 2,469 | 2,078 | $15K | |
| 84156 | 44,282 | 36,786 | $15K | |
| 84270 | 7,838 | 7,078 | $15K | |
| 82653 | 1,017 | 895 | $14K | |
| 81596 | 2,124 | 1,851 | $14K | |
| 82542 | 2,503 | 2,094 | $14K | |
| 81241 | 730 | 647 | $14K | |
| 82330 | 4,214 | 3,542 | $14K | |
| 84482 | 1,442 | 1,226 | $14K | |
| 86709 | 3,374 | 3,113 | $14K | |
| 80069 | 22,251 | 17,837 | $13K | |
| 80346 | 2,342 | 2,191 | $13K | |
| 87906 | 559 | 461 | $13K | |
| 82247 | 10,654 | 8,680 | $13K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 22,750 | 18,615 | $13K |
| 81003 | 51,805 | 45,580 | $13K | |
| 87255 | 939 | 865 | $12K | |
| 80354 | 1,428 | 1,333 | $12K | |
| 85240 | 1,384 | 1,301 | $12K | |
| 82140 | 5,822 | 4,809 | $12K | |
| 88312 | 503 | 387 | $12K | |
| 87529 | 532 | 354 | $12K | |
| 82657 | 1,524 | 540 | $11K | |
| 86431 | 25,223 | 22,168 | $11K | |
| 85045 | 13,166 | 11,558 | $11K | |
| 82668 | 2,077 | 1,693 | $11K | |
| 80320 | 1,534 | 1,432 | $11K | |
| 83718 | 4,439 | 4,286 | $11K | |
| 80365 | 4,248 | 4,011 | $11K | |
| 82390 | 2,280 | 2,041 | $11K | |
| 87147 | 25,945 | 22,739 | $10K | |
| 80178 | 4,624 | 3,852 | $10K | |
| 86870 | 2,249 | 2,105 | $10K | |
| 82248 | 31,880 | 26,707 | $10K | |
| 80156 | 3,027 | 2,611 | $10K | |
| 80177 | 7,207 | 5,863 | $10K | |
| 80321 | 941 | 864 | $10K | |
| 86335 | 2,023 | 1,662 | $10K | |
| 83519 | 2,353 | 1,247 | $10K | |
| 85018 | 17,653 | 15,839 | $9K | |
| 86900 | 13,382 | 12,393 | $9K | |
| 84703 | 7,708 | 7,037 | $9K | |
| 83010 | 2,184 | 1,824 | $9K | |
| 88341 | 983 | 600 | $9K | |
| 86705 | 3,838 | 3,554 | $9K | |
| 82088 | 1,108 | 940 | $9K | |
| 84425 | 4,287 | 3,693 | $8K | |
| 87329 | 7,247 | 6,569 | $8K | |
| 88313 | 146 | 111 | $8K | |
| 86162 | 2,774 | 2,457 | $8K | |
| 82787 | 1,135 | 955 | $8K | |
| 82040 | 8,068 | 7,006 | $8K | |
| 86039 | 10,640 | 9,423 | $8K | |
| 81257 | 96 | 94 | $7K | |
| 87427 | 11,307 | 10,112 | $7K | |
| 84165 | 11,908 | 9,822 | $7K | |
| 85379 | 2,440 | 2,090 | $7K | |
| 82952 | 9,367 | 8,883 | $7K | |
| 87045 | 12,179 | 10,890 | $7K | |
| 85014 | 15,066 | 13,553 | $7K | |
| 86812 | 1,045 | 941 | $6K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 7,067 | 5,310 | $6K |
| 86258 | 481 | 375 | $6K | |
| 82565 | 14,691 | 12,174 | $6K | |
| 86141 | 6,478 | 5,448 | $6K | |
| 80202 | 3,109 | 1,268 | $6K | |
| 80324 | 902 | 868 | $6K | |
| 84100 | 27,151 | 20,298 | $6K | |
| 87040 | 1,928 | 1,254 | $6K | |
| 82310 | 9,234 | 7,971 | $6K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 201 | 195 | $6K |
| 84460 | 13,551 | 11,696 | $6K | |
| 83014 | 4,808 | 4,479 | $5K | |
| 87102 | 1,774 | 1,529 | $5K | |
| 86381 | 1,206 | 1,047 | $5K | |
| 84134 | 1,873 | 1,393 | $5K | |
| 80175 | 3,511 | 2,909 | $5K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 5,711 | 4,589 | $5K |
| 86645 | 1,414 | 1,284 | $5K | |
| 87101 | 1,519 | 1,309 | $5K | |
| 82139 | 313 | 283 | $5K | |
| 84520 | 9,626 | 8,270 | $5K | |
| 85300 | 464 | 404 | $5K | |
| 84432 | 2,317 | 2,013 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 563 | 380 | $5K |
| 85306 | 694 | 578 | $5K | |
| 86901 | 13,563 | 12,560 | $5K | |
| 85060 | 966 | 909 | $5K | |
| 85613 | 2,911 | 2,532 | $4K | |
| 80358 | 2,090 | 1,953 | $4K | |
| 83835 | 448 | 369 | $4K | |
| 83003 | 348 | 232 | $4K | |
| 84450 | 12,737 | 10,934 | $4K | |
| 86060 | 449 | 420 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 974 | 777 | $4K |
| 82232 | 1,257 | 1,025 | $4K | |
| 86359 | 8,670 | 7,243 | $4K | |
| 86664 | 3,599 | 3,294 | $4K | |
| 87493 | 970 | 832 | $4K | |
| 80185 | 2,645 | 2,153 | $4K | |
| 84182 | 80 | 66 | $4K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 12,455 | 10,020 | $3K |
| 82104 | 447 | 397 | $3K | |
| 80353 | 981 | 922 | $3K | |
| 86015 | 1,362 | 1,189 | $3K | |
| 86593 | 7,787 | 6,690 | $3K | |
| 82172 | 2,724 | 2,432 | $3K | |
| 87535 | 97 | 88 | $3K | |
| 80299 | 1,186 | 980 | $3K | |
| 82610 | 452 | 415 | $3K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 2,628 | 2,169 | $3K |
| 84075 | 7,048 | 6,093 | $3K | |
| 86778 | 1,207 | 1,102 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 17,113 | 14,807 | $3K |
| 85245 | 1,077 | 1,038 | $3K | |
| 84155 | 12,175 | 10,217 | $3K | |
| 86618 | 1,384 | 1,169 | $3K | |
| 80165 | 1,383 | 1,177 | $3K | |
| 87324 | 4,735 | 3,994 | $3K | |
| 80051 | 2,741 | 2,385 | $3K | |
| 82397 | 1,612 | 1,461 | $3K | |
| 84166 | 2,526 | 2,133 | $3K | |
| 80345 | 1,572 | 1,466 | $3K | |
| 80183 | 1,430 | 1,194 | $3K | |
| 86702 | 1,792 | 1,569 | $3K | |
| 80159 | 1,262 | 888 | $2K | |
| 89055 | 1,635 | 1,393 | $2K | |
| 84630 | 3,087 | 2,696 | $2K | |
| 83721 | 5,570 | 4,756 | $2K | |
| 85041 | 6,562 | 6,011 | $2K | |
| 80184 | 1,096 | 947 | $2K | |
| 86880 | 1,241 | 1,027 | $2K | |
| 86308 | 499 | 463 | $2K | |
| 83704 | 1,316 | 1,185 | $2K | |
| 82747 | 996 | 846 | $2K | |
| 82530 | 419 | 326 | $2K | |
| 80356 | 799 | 757 | $2K | |
| 80377 | 1,086 | 1,015 | $2K | |
| 84590 | 1,201 | 1,056 | $2K | |
| 83883 | 2,476 | 1,231 | $2K | |
| 82575 | 637 | 567 | $2K | |
| 84478 | 3,958 | 2,811 | $2K | |
| 82164 | 1,559 | 1,332 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 93 | 82 | $2K |
| 80162 | 722 | 591 | $2K | |
| 83992 | 1,245 | 1,153 | $2K | |
| 83695 | 2,394 | 2,102 | $2K | |
| 80362 | 717 | 650 | $2K | |
| 84244 | 1,013 | 865 | $2K | |
| 82525 | 1,443 | 1,220 | $2K | |
| 86774 | 914 | 844 | $1K | |
| 80370 | 1,104 | 1,027 | $1K | |
| 80368 | 1,128 | 1,043 | $1K | |
| 86337 | 234 | 216 | $1K | |
| 80337 | 1,272 | 1,190 | $1K | |
| 85303 | 684 | 602 | $1K | |
| 80338 | 1,288 | 1,207 | $1K | |
| 85004 | 1,214 | 1,071 | $1K | |
| 82985 | 1,936 | 1,620 | $1K | |
| 80235 | 299 | 227 | $1K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1,722 | 1,453 | $1K |
| 86701 | 1,811 | 1,586 | $1K | |
| 81240 | 302 | 267 | $1K | |
| 84132 | 1,793 | 1,530 | $1K | |
| 87662 | 102 | 98 | $1K | |
| 86794 | 173 | 163 | $1K | |
| 80363 | 875 | 828 | $1K | |
| 82705 | 521 | 448 | $1K | |
| 80326 | 1,271 | 1,189 | $1K | |
| 87350 | 512 | 451 | $1K | |
| 86355 | 1,787 | 1,518 | $1K | |
| 85049 | 1,259 | 1,120 | $1K | |
| 80332 | 853 | 809 | $1K | |
| 87425 | 146 | 128 | $1K | |
| 81015 | 3,992 | 3,541 | $1K | |
| 86231 | 162 | 144 | $1K | |
| 85384 | 329 | 300 | $1K | |
| 87076 | 2,195 | 1,817 | $1K | |
| 80339 | 1,060 | 1,007 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,067 | 987 | $1K |
| 86357 | 1,245 | 1,035 | $1K | |
| 80342 | 852 | 808 | $1K | |
| 82166 | 107 | 105 | $1K | |
| 81381 | 76 | 68 | $937.15 | |
| 80158 | 526 | 382 | $903.15 | |
| 80329 | 1,072 | 1,018 | $879.64 | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 528 | 499 | $870.24 |
| 86036 | 900 | 800 | $868.34 | |
| 85598 | 158 | 143 | $838.71 | |
| 82955 | 563 | 501 | $830.43 | |
| 87206 | 2,328 | 1,877 | $780.73 | |
| 84080 | 243 | 210 | $772.28 | |
| 85048 | 2,044 | 1,787 | $755.72 | |
| 87650 | 151 | 138 | $743.43 | |
| 87807 | 160 | 138 | $735.95 | |
| 82340 | 368 | 326 | $719.75 | |
| 87106 | 540 | 478 | $713.88 | |
| 86648 | 660 | 609 | $704.95 | |
| 81206 | 47 | 37 | $671.54 | |
| 84484 | 252 | 207 | $630.10 | |
| 86340 | 134 | 114 | $556.58 | |
| 80372 | 184 | 170 | $541.49 | |
| 85007 | 3,858 | 3,344 | $515.51 | |
| 84295 | 2,370 | 2,022 | $506.49 | |
| 83698 | 640 | 573 | $484.77 | |
| 87185 | 1,011 | 883 | $474.97 | |
| 86671 | 537 | 277 | $461.54 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 2,935 | 2,434 | $411.04 |
| 82435 | 2,168 | 1,850 | $410.30 | |
| 86886 | 639 | 603 | $407.48 | |
| 83605 | 143 | 127 | $388.97 | |
| 84300 | 1,575 | 1,318 | $361.29 | |
| 82374 | 1,818 | 1,550 | $360.49 | |
| 84140 | 202 | 177 | $356.22 | |
| 86148 | 208 | 98 | $351.05 | |
| 86738 | 77 | 76 | $346.79 | |
| 86617 | 327 | 219 | $332.63 | |
| 86382 | 13 | 13 | $322.88 | |
| 80201 | 177 | 148 | $316.62 | |
| 84446 | 489 | 431 | $309.64 | |
| 83935 | 316 | 261 | $306.98 | |
| 80357 | 159 | 148 | $302.31 | |
| 80195 | 270 | 204 | $294.49 | |
| 81291 | 89 | 85 | $276.64 | |
| 87328 | 137 | 122 | $274.22 | |
| 80355 | 235 | 217 | $270.90 | |
| 86316 | 54 | 40 | $256.58 | |
| 80369 | 368 | 352 | $251.15 | |
| 80360 | 75 | 68 | $233.75 | |
| 86747 | 141 | 134 | $230.40 | |
| 82523 | 34 | 24 | $213.85 | |
| 84376 | 235 | 221 | $197.69 | |
| 83789 | 14 | 14 | $187.18 | |
| 87521 | Neg quan hep c or qual rna | 129 | 116 | $186.30 |
| 82175 | 12 | 12 | $176.14 | |
| 83986 | 137 | 126 | $161.91 | |
| 87220 | 793 | 653 | $157.48 | |
| 84145 | 17 | 13 | $154.93 | |
| 86001 | 160 | 133 | $152.70 | |
| 84210 | 56 | 52 | $148.31 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 774 | 639 | $148.19 |
| 86707 | 241 | 214 | $139.43 | |
| 80359 | 71 | 65 | $136.26 | |
| 80330 | 139 | 128 | $134.62 | |
| 87116 | 83 | 62 | $132.62 | |
| 84133 | 391 | 340 | $120.13 | |
| 87467 | 14 | 13 | $118.38 | |
| 84378 | 491 | 368 | $117.54 | |
| 82379 | 233 | 215 | $116.37 | |
| 88164 | 14 | 14 | $107.35 | |
| 83930 | 149 | 120 | $104.09 | |
| 80364 | 41 | 36 | $99.87 | |
| 80333 | 43 | 37 | $96.87 | |
| 80367 | 30 | 26 | $95.31 | |
| 83625 | 15 | 13 | $90.24 | |
| 80340 | 43 | 37 | $82.97 | |
| 80344 | 43 | 37 | $77.38 | |
| 82656 | 234 | 219 | $76.08 | |
| 87015 | 250 | 190 | $73.63 | |
| 87272 | 174 | 158 | $60.19 | |
| 86684 | 30 | 30 | $59.76 | |
| 83630 | 15 | 14 | $52.76 | |
| 82608 | 90 | 89 | $51.09 | |
| 80366 | 31 | 26 | $33.19 | |
| 86905 | 211 | 195 | $25.17 | |
| 82436 | 54 | 51 | $24.88 | |
| 83527 | 35 | 34 | $21.24 | |
| 84255 | 16 | 12 | $19.32 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 81 | 80 | $18.88 |
| 85302 | 26 | 24 | $17.02 | |
| 85597 | 27 | 25 | $15.36 | |
| 86161 | 15 | 15 | $15.13 | |
| 87107 | 126 | 95 | $14.63 | |
| 83825 | 16 | 12 | $13.57 | |
| 86611 | 37 | 34 | $12.98 | |
| 82239 | 15 | 13 | $12.48 | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 890 | 736 | $12.44 |
| 87254 | 14 | 13 | $10.62 | |
| 86663 | 15 | 15 | $10.62 | |
| 86256 | 96 | 90 | $8.38 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 1,227 | 1,125 | $5.90 |
| 82384 | 15 | 12 | $5.90 | |
| 82679 | 13 | 13 | $5.90 | |
| 86343 | 13 | 13 | $5.90 | |
| 85385 | 13 | 13 | $5.47 | |
| 83631 | 29 | 28 | $4.72 | |
| 87140 | 33 | 29 | $4.46 | |
| 84560 | 41 | 40 | $3.65 | |
| 84252 | 27 | 26 | $3.33 | |
| 82017 | 40 | 36 | $2.36 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 193 | 166 | $2.07 |
| 88262 | 385 | 354 | $0.00 | |
| 83918 | 95 | 83 | $0.00 | |
| 87184 | 30 | 27 | $0.00 | |
| 85305 | 15 | 14 | $0.00 |